In vitro activity of biapenem against Burkholderia pseudomallei

International Journal of Antimicrobial Agents

Volumn 35, Issue 5, 2010, Pages 514-

  Thamlikitkul, Visanu ^a   Trakulsomboon, Suwanna ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BIAPENEM; CEFTAZIDIME; DORIPENEM; IMIPENEM; MEROPENEM;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; ESCHERICHIA COLI; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL;

ANTI-BACTERIAL AGENTS; BURKHOLDERIA PSEUDOMALLEI; HUMANS; MELIOIDOSIS; MICROBIAL SENSITIVITY TESTS; THIENAMYCINS;

EID: 77949657811     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.01.002     Document Type: Letter

References (5)

1. White N.J. Melioidosis. Lancet 2003, 361:1715-1722.
2. Dance D.A., Wuthiekanun V., Chaowagul W., Suputtamongkol Y., White N.J. Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei. J Antimicrob Chemother 1991, 28:321-324.
3. Wuthiekanun V., Cheng A.C., Chierakul W., Amornchai P., Limmathurotsakul D., Chaowagul W., et al. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother 2005, 55:1029-1031.
4. Perry C.M., Ibbotson T. Biapenem. Drugs 2002, 62:2221-2234.
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; approved standard. Fifteenth informational supplement. Document M100-S15. Wayne, PA: CLSI; 2005.